The Cancer Targeted Therapy Market was valued at US$ 95.12 Billion in 2024 and is projected to reach US$ 235.68 Billion by 2031, registering a CAGR of 13.84% during 2025–2031. This version emphasizes balanced demand, technology, competition, and execution. Decision-makers should connect market growth to verified customer needs, operating constraints, and measurable value. What is driving...